Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
The inquests have heard that Mr Marshall did not check for signs of life on people in the immediate aftermath of the disaster.
Update for Yorkshire and Lincolnshire with Jon Mitchell.
Approximately 65 firefighters have been tackling a blaze at a waste site in Hull.